Clinical trials recruiting in Obninsk, Russia

Phase breakdown

Conditions recruiting in Obninsk, Russia

Recruiting trials in Obninsk, Russia

• A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI
  NCT07543744 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female)
• A Long-term Extension Study of PCI-32765 (Ibrutinib)
  NCT01804686 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration
  NCT07052578 · Phase: Not specified · Ages: 18 Years and older · Sex: Male
• BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer
  NCT07108309 · Phase: Phase 2 · Ages: 18 Years to 74 Years · Sex: Female

Common questions

How many clinical trials are recruiting in Obninsk, Russia?

4 recruiting trials have at least one study site in Obninsk, Russia.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.